tetradecanoylphorbol acetate has been researched along with HIGM1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Ramadi, BK; Al-Sbiei, A; Amarante-Mendes, GP; Cabral-Marques, O; Calich, VLG; Condino-Neto, A; Costa-Carvalho, BT; da Costa, TA; Di Gesu, RSW; Feriotti, C; Fernandez-Cabezudo, MJ; Ferreira, JF; França, TT; Iqbal, A; Junior, OR; Khan, TA; Marzagão Barbuto, JA; Notarangelo, LD; Ochs, HD; Pereira, PVS; Riemekasten, G; Schimke, LF; Tavares, FS; Torgerson, TR; Valente, C; Weber, CW | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and HIGM1
Article | Year |
---|---|
CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.
Topics: Animals; CD40 Ligand; Female; HL-60 Cells; Humans; Hyper-IgM Immunodeficiency Syndrome, Type 1; Interferon-gamma; Mice, Inbred C57BL; Mice, Knockout; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Paracoccidioides; Reactive Oxygen Species; Recombinant Proteins; Respiratory Burst; Staphylococcus aureus; Tetradecanoylphorbol Acetate; Transcriptome | 2018 |